Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Free Access

Dental Plaque as a Microbial Biofilm

Marsh P.D.

Author affiliations

Leeds Dental Institute and Health Protection Agency, Porton Down, Salisbury, UK

Corresponding Author

Prof. P.D. Marsh

Health Protection Agency Porton Down

Centre for Applied Microbiology & Research

Salisbury, SP4 0JG (UK)

Tel. +44 1980 612287, Fax +44 1980 612731, E-Mail phil.marsh@hpa.org.uk

Related Articles for ""

Caries Res 2004;38:204–211

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

New technologies have provided novel insights into how dental plaque functions as a biofilm. Confocal microscopy has confirmed that plaque has an open architecture similar to other biofilms, with channels and voids. Gradients develop in areas of dense biomass over short distances in key parameters that influence microbial growth and distribution. Bacteria exhibit an altered pattern of gene expression either as a direct result of being on a surface or indirectly as a response to the local environmental heterogeneity within the biofilm. Bacteria communicate via small diffusible signalling molecules (e.g. competence-stimulating peptide, CSP; autoinducer 2); CSP induces both genetic competence and acid tolerance in recipient sessile cells. Thus, rates of gene transfer increase in biofilm communities, and this is one of several mechanisms (others include: diffusion-reaction, neutralization/inactivation, slow growth rates, novel phenotype) that contribute to the increased antimicrobial resistance exhibited by bacteria in biofilms. Oral bacteria in plaque do not exist as independent entities but function as a co-ordinated, spatially organized and fully metabolically integrated microbial community, the properties of which are greater than the sum of the component species. A greater understanding of the significance of dental plaque as a mixed culture biofilm will lead to novel control strategies.

© 2004 S. Karger AG, Basel


References

  1. Abraham SN, Jonsson A-B, Normark S: Fimbriae-mediated host pathogen cross-talk. Curr Opin Microbiol 1998;1:75–81.
  2. Al-Hashimi I, Levine MJ: Characterization of in vivo saliva-derived enamel pellicle. Arch Oral Biol 1989;34:289–295.
  3. Allison D, Gilbert P, Lappin-Scott HM, Wilson M: Community Structure and Co-Operation in Biofilms. Society for General Microbiology Symposium 59. Cambridge, Cambridge University Press, 2000.
  4. Allison DG: The biofilm matrix. Biofouling 2003;19:139–150.
    External Resources
  5. Anwar H, Dasgupta MK, Costerton JW: Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother 1990;34:2043–2046.
  6. Auschill TM, Arweiler NB, Netuschil L, Brecx M, Reich E, Sculean A: Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol 2001;46:471–476.
  7. Beighton D, Smith K, Hayday H: The growth of bacteria and the production of exoglycosidic enzymes in the dental plaque of macaque monkeys. Arch Oral Biol 1986;31:829–835.
  8. Blehert DS, Palmer RJ Jr, Xavier JB, Almeida JS, Kolenbrander P: Autoinducer 2 production by Streptococcus gordonii DL1 and the biofilm phenotype of a luxS mutant are influenced by nutritional conditions. J Bacteriol 2003;185:4851–4860.
  9. Bowden GH, Hardie JM, Slack GL: Microbial variations in approximal dental plaque. Caries Res 1975;9:253–277.
  10. Bowler LD, Zhang Q-Y, Riou J-Y, Spratt BG: Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: Natural events and laboratory simulation. J Bacteriol 1994;176:333–337.
  11. Boyd A, Chakrabarty AM: Pseudomonas aeruginosa biofilms: Role of the alginate exopolysaccharide. J Ind Microbiol 1995;15:162–168.
  12. Bradshaw DJ, Homer KA, Marsh PD, Beighton D: Metabolic cooperation in oral microbial communities during growth on mucin. Microbiology 1994;140:3407–3412.
  13. Bradshaw DJ, Marsh PD, Watson GK, Allison C: Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 1998;66:4729–4732.
  14. Burne RA: Regulation of gene expression in adherent populations of oral streptococci; in LeBlanc DJ, Lantz MS, Switalski LM (eds): Microbial Pathogenesis: Current and Emerging Issues. Indianapolis, Indiana University, 1998, pp 41–53.
  15. Busscher HJ, van der Mei HC: Physico-chemical interactions in initial microbial adhesion and relevance for biofilm formation. Adv Dent Res 1997;11:24–32.
  16. Caldwell DE, Wolfaardt GM, Korber DR, Lawrence JR: Do bacterial communities transcend Darwinism? in Jones JG (ed): Advances in Microbial Ecology. New York, Plenum Press, 1997, vol 15, pp 105–191.
  17. Cavedon K, London J: Adhesin degradation: A possible function for a Prevotella loescheii protease? Oral Microbiol Immunol 1993;8:283–287.
  18. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A: The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771–1776.
  19. Dewhirst FE, Tamer MA, Ericson RE, Lau CN, Levanos VA, Boches SK, Galvin JL, Paster BJ: The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol Immunol 2000;15:196–202.
  20. Dowson CG, Hutchison A, Woodford N, Johnson AP, George RC, Spratt BG: Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1990;87:5858–5862.
  21. Du LD, Kolenbrander PE: Identification of saliva-regulated genes of Streptococcus gordonii DL1 by differential display using random arbitrarily primed PCR. Infect Immun 2000;68:4834–4837.
  22. Gelle MP, Jacquelin LF, Choisy C: Compare viability of planctonic bacteria and bacteria in biofilms by flow cytometry. Ann Pharm Fr 2003;61:243–252.
  23. Gilbert P, Das J, Foley I: Biofilm susceptibility to antimicrobials. Adv Dent Res 1997;11:160–167.
  24. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW: The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002;46:203–255.
  25. Hakenbeck R, Konog A, Kern I, van der Linden M, Keck W, Billot-Klein D, Legrand R, Schoot B, Gutmann L: Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae. J Bacteriol 1998;180:1831–1840.
  26. Haubek D, Ennibi OK, Poulsen K, Poulsen S, Benzarti N, Kilian M: Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J Dent Res 2001;80:1580–1583.
  27. Herrera D, van Winkelhoff AJ, Dellemijn-Kippuw N, Winkel EG, Sanz M: Beta-lactamase producing bacteria in the subgingival microflora of adult patients with periodontitis: A comparison between Spain and the Netherlands. J Clin Periodontol 2000;27:520–525.
  28. Hillman JD: Replacement therapy of dental caries; in Newman HN, Wilson M (eds): Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, BioLine, 1999, pp 587–599.
  29. Hol C, van Dijke EEM, Verduin CM, Verhoef J, van Dijk H: Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis 1994;170:1613–1616.
  30. Hope CK, Wilson M: Cell viability within oral biofilms; in McBain A, Allison D, Brading M, Rickard A, Verran J, Walker J (eds): Biofilm Communities: Order from Chaos? Cardiff, BioLine, 2003, pp 269–284.
  31. Jenkinson HF, Lamont RJ: Streptococcal adhesion and colonization. Crit Rev Oral Biol Med 1997;8:175–200.
  32. Johnson SA, Goddard PA, Iliffe C, Timmins B, Rickard AH, Robson G, Handley PS: Comparative susceptibility of resident and transient hand bacteria to para-chloro-meta-xylenol and triclosan. J Appl Microbiol 2002;93:336–344.
  33. Kinniment SL, Wimpenny JWT, Adams D, Marsh PD: The effect of chlorhexidine on defined, mixed culture oral biofilms grown in a novel model system. J Appl Bacteriol 1996;81:120–125.
  34. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ: Communication among oral bacteria. Microbiol Mol Biol Rev 2002;66:486–450.
  35. Kolenbrander PE, Andersen RN, Kazmerak KM, Palmer RJ: Coaggregation and coadhesion in oral biofilms; in Allison DG, Gilbert P, Lappin-Scott HM, Wilson M (eds): Community Structure and Co-Operation in Biofilms. Society for General Microbiology Symposium 59. Cambridge, Cambridge University Press, 2000, pp 65–85.
  36. Kopec LK, Vacca-Smith AM, Wunder D, Ng-Evans L, Bowen WH: Properties of Streptococcus sanguinis glucans formed under various conditions. Caries Res 2001;35:67–74.
  37. Kroes I, Lepp PW, Relman DA: Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci USA 1999;96:14547–14552.
  38. Lamont RJ, Jenkinson HF: Adhesion as an ecological determinant in the oral cavity; in Kuramitsu HK, Ellen RP (eds): Oral Bacterial Ecology: The Molecular Basis. Wymondham, Horizon Scientific Press, 2000, pp 131–168.
  39. Larsen T: Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 2002;17:267–271.
  40. Larsen T, Fiehn NE: Resistance of Streptococcus sanguis biofilms to antimicrobial agents. APMIS B 1996;104:280–284.
  41. Lee SF, Li YH, Bowden GWH: Detachment of Streptococcus mutans biofilm cells by an endogenous enzyme activity. Infect Immun 1996;64:1035–1038.
  42. Li J, Helmerhorst EJ, Corley RB, Luus LE, Troxler LE, Oppenheim FG: Characterization of the immunologic responses to human in vivo acquired enamel pellicle as a novel means to investigate its composition. Oral Microbiol Immunol 2003;18:183–191.
  43. Li Y, Burne RA: Regulation of the gtfBC and ftf genes of Streptococcus mutans in biofilms in response to pH and carbohydrate. Microbiology 2001;147:2841–2848.
  44. Li Y-H, Lau PCY, Lee JH, Ellen RP, Cvitkovitch DG: Natural genetic transformation of Streptococcus mutans growing in biofilms. Infect Immun 2001;183:897–908.
    External Resources
  45. Li Y-H, Lau PCY, Tang N, Svensater G, Ellen RP, Cvitkovitch DG: Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. J Bacteriol 2002a;184:6333–6342.
  46. Li Y-H, Tang N, Aspiras MB, Lau PCY, Lee JH, Ellen RP, Cvitkovitch DG: A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J Bacteriol 2002b;184:2699–2708.
  47. Listgarten M: Formation of dental plaque and other biofilms; in Newman HN, Wilson M, (eds): Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, BioLine, 1999, pp 187–210.
  48. Loo CY: Oral streptococcal genes that encode biofilm formation; in Wilson M, Devine DA (eds): Medical Implications of Biofilms. Cambridge, Cambridge University Press, 2003, pp 189–211.
  49. Marsh PD: Oral ecology and its impact on oral microbial diversity; in Kuramitsu HK, Ellen RP (eds): Oral Bacterial Ecology: The Molecular Basis. Wymondham, Horizon Scientific Press, 2000a, pp 11–65.
  50. Marsh PD: Role of the oral microflora in health. Microb Ecol Health Dis 2000b;12:130–137.
  51. Marsh PD: Are dental diseases examples of ecological catastrophes? Microbiology 2003;149:279–294.
  52. Marsh PD, Bowden GHW: Microbial community interactions in biofilms; in Allison DG, Gilbert P, Lappin-Scott HM, Wilson M (eds): Community Structure and Co-Operation in Biofilms. Society for Microbiology Symposium 59. Cambridge, Cambridge University Press, 2000, pp 167–198.
  53. Marsh PD, Bradshaw DJ: Microbiological effects of new agents in dentifrices for plaque control. Int Dent J 1993;43:399–406.
  54. Marsh PD, Bradshaw DJ: Microbial community aspects of dental plaque; in Newman HN, Wilson M (eds): Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, BioLine, 1999, pp 237–253.
  55. Marsh PD, Nyvad B: The oral microflora and biofilms on teeth; in Fejerskov O, Kidd EAM, (eds): Dental Caries: The Disease and Its Clinical Management. Oxford, Blackwell, 2003, pp 29–48.
  56. McFarland LV: Normal flora: Diversity and functions. Microb Ecol Health Dis 2000;12:193–207.
    External Resources
  57. Merritt J, Qi F, Goodman SD, Anderson MH, Shi W: Mutation of luxS affects biofilm formation in Streptococcus mutans. Infect Immun 2003;71:1972–1979.
  58. Millward TA, Wilson M: The effect of chlorhexidine on Streptococcus sanguis biofilms. Microbios 1989;58:155–164.
  59. Munson MA, Banerjee A, Watson TF, Wade WG: Molecular analysis of the microflora associated with dentinal caries (abstract). Caries Res 2003;37:297.
  60. Newman HN, Wilson M (eds): Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, BioLine, 1999.
  61. Nichols WW: Biofilm permeability to antibacterial agents; in Wimpenny J, Nichols W, Stickler D, Lappin-Scott H (eds): Bacterial Biofilms and Their Control in Medicine and Industry. Cardiff, BioLine, 1994, pp 141–149.
  62. Nyvad B: Microbial colonization of human tooth surfaces. APMIS B 1993;101:7–45.
  63. Paster BJ, Bosches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE: Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183:3770–3783.
  64. Percival RS, Challacombe SJ, Marsh PD: Age-related microbiological changes in the salivary and plaque microflora of healthy adults. J Med Microbiol 1991;35:5–11.
  65. Pratten J, Wilson M: Antimicrobial susceptibility and composition of microcosm dental plaques supplemented with sucrose. Antimicrob Agents Chemother 1999;43:1595–1599.
  66. Redmo-Emanuelsson IM, Carlsson P, Hamberg K, Bratthall D: Tracing genotypes of mutans streptococci on tooth sites by random amplified polymorphic DNA (RAPD) analysis. Oral Microbiol Immunol 2003;18:24–29.
  67. Roberts AP, Cheah G, Ready D, Pratten J, Wilson M, Mullany P: Transfer of TN916-like elements in microcosm dental plaques. Antimicrob Agents Chemother 2001;45:2943–2946.
  68. Robinson C, Kirkham J, Percival R, Shore RC, Bonass WA, Brookes SJ, Kusa L, Nakagaki H, Kato K, Nattress B: A method for the quantitative site-specific study of the biochemistry within dental plaque biofilms formed in vivo. Caries Res 1997;31:194–200.
  69. Shani S, Friedman M, Steinberg D: The anticariogenic effect of amine fluorides on Streptococcus sobrinus and glucosyltransferase in biofilms. Caries Res 2000;34:260–267.
  70. Shapiro JA: Thinking about bacterial populations as multicellular organisms. Annu Rev Microbiol 1998;52:81–104.
  71. Slots J: Microflora in the healthy gingival sulcus in man. Scand J Dent Res 1977;85:247–254.
  72. Svensater G, Welin J, Wilkins JC, Beighton D, Hamilton IR: Protein expression by planktonic and biofilm cells of Streptococcus mutans. FEMS Microbiol Lett 2001;205:139–146.
    External Resources
  73. Tagg JR, Dierksen KP: Bacterial replacement therapy: Adapting ‘germ warfare’ to infection prevention. Trends Biotechnol 2003;21:217–223.
  74. Theilade E, Fejerskov O, Karring T, Theilade J: Predominant cultivable microflora of human dental fissure plaque. Infect Immun 1982;36:977–982.
  75. Thurnheer T, Gmur R, Giertsen E, Guggenheim B: Automated fluorescent in situ hybridization for the specific detection and quantification of oral streptococci in dental plaque. J Microbiol Methods 2001;44:39–47.
  76. Thurnheer T, Gmur R, Shapiro S, Guggenheim B: Mass transport of macromolecules within an in vitro model of supragingival plaque. Appl Environ Microbiol 2003;69:1702–1709.
  77. Vacca-Smith AM, Venkitaraman AR, Schilling KM, Bowen WH: Characterization of glucosyltransferase of human saliva adsorbed onto hydroxyapatite surfaces. Caries Res 1996;30:354–360.
  78. Vroom JM, de Grauw KJ, Gerritsen HC, Bradshaw DJ, Marsh PD, Watson GK, Allison C, Birmingham JJ: Depth penetration and detection of pH gradients in biofilms using two-photon excitation microscopy. Appl Environ Microbiol 1999;65:3502–3511.
  79. Wade W: Unculturable bacteria in oral biofilms; in Newman HN, Wilson M (eds): Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, BioLine, 1999, pp 313–322.
  80. Walker CB, Tyler KT, Low SB, King CJ: Penicillin-degrading enzymes in sites associated with adult periodontitis. Oral Microbiol Immunol 1987;2:129–131.
  81. Wecke J, Kersten T, Madela K, Moter A, Gobel UB, Friedmannn A, Bernimoulin J: A novel technique for monitoring the development of bacterial biofilms in human periodontal pockets. FEMS Microbiol Lett 2000;191:95–101.
  82. Wilson M: Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996;44:79–87.
  83. Wood SR, Kirkham J, Marsh PD, Shore RC, Nattress B, Robinson C: Architecture of intact natural human plaque biofilms studied by confocal laser scanning microscopy. J Dent Res 2000;79:21–27.
  84. Zaura-Arite E, van Marle J, ten Cate JM: Confocal microscopy study of undisturbed and chlorhexidine-treated dental biofilm. J Dent Res 2001;80:1436–1440.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: May 21, 2004
Issue release date: May – June

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 1

ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)

For additional information: https://www.karger.com/CRE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.